Review
doi: 10.1164/rccm.2304001.
Eosinophils and interleukin-5: the debate continues
- PMID: 12796050
- DOI: 10.1164/rccm.2304001
Item in Clipboard
Review
Eosinophils and interleukin-5: the debate continues
Am J Respir Crit Care Med.
.
No abstract available
Comment on
-
Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.Am J Respir Crit Care Med. 2003 Jun 15;167(12):1655-9. doi: 10.1164/rccm.200206-525OC. Epub 2003 Mar 20. Am J Respir Crit Care Med. 2003. PMID: 12649124 Clinical Trial.
Similar articles
-
Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.Am J Respir Crit Care Med. 2003 Jun 15;167(12):1655-9. doi: 10.1164/rccm.200206-525OC. Epub 2003 Mar 20. Am J Respir Crit Care Med. 2003. PMID: 12649124 Clinical Trial.
-
Eosinophils in asthma--closing the loop or opening the door?N Engl J Med. 2009 Mar 5;360(10):1026-8. doi: 10.1056/NEJMe0900334. N Engl J Med. 2009. PMID: 19264692 No abstract available.
-
Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.Ann Allergy Asthma Immunol. 2018 Jul;121(1):121-123. doi: 10.1016/j.anai.2018.04.016. Epub 2018 Apr 21. Ann Allergy Asthma Immunol. 2018. PMID: 29684570 No abstract available.
-
Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies.J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1430-1436. doi: 10.1016/j.jaip.2019.03.010. Epub 2019 Apr 5. J Allergy Clin Immunol Pract. 2019. PMID: 30962155 Review. No abstract available.
-
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.Drug Des Devel Ther. 2017 Oct 30;11:3137-3144. doi: 10.2147/DDDT.S150656. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29133975 Free PMC article. Review.
Cited by
-
Serum interleukin-5 levels are elevated in mild and moderate persistent asthma irrespective of regular inhaled glucocorticoid therapy.BMC Pulm Med. 2004 Mar 17;4:2. doi: 10.1186/1471-2466-4-2. BMC Pulm Med. 2004. PMID: 15113433 Free PMC article.
-
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma.Front Med (Lausanne). 2017 Aug 31;4:135. doi: 10.3389/fmed.2017.00135. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28913336 Free PMC article. Review.
-
Stratified approaches to the treatment of asthma.Br J Clin Pharmacol. 2013 Aug;76(2):277-91. doi: 10.1111/bcp.12036. Br J Clin Pharmacol. 2013. PMID: 23163316 Free PMC article. Review.
-
New drugs targeting Th2 lymphocytes in asthma.J Occup Med Toxicol. 2008 Feb 27;3 Suppl 1(Suppl 1):S6. doi: 10.1186/1745-6673-3-S1-S6. J Occup Med Toxicol. 2008. PMID: 18315837 Free PMC article.
-
Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly.Cytokine. 2008 May;42(2):179-190. doi: 10.1016/j.cyto.2007.12.010. Epub 2008 Feb 21. Cytokine. 2008. PMID: 18294864 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
